BAY1217389 is a potent, and selective inhibitor of the monopolar spindle 1 (MPS1) kinase with an IC50 value less than 10 nM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | BAY 1217389 inhibits Mps1 kinase activity with an IC50 value below 10 nM and demonstrates excellent selectivity. In cellular mechanistic assays, BAY 1217389 disrupts nocodazole-induced spindle assembly checkpoint (SAC) activity and triggers premature exit from mitosis, leading to multinuclearity and tumor cell death. Moreover, BAY 1217389 efficiently suppresses tumor cell proliferation in vitro[1]. |
Animal study | BAY 1217389 demonstrates moderate efficacy as a monotherapy in tumor xenograft studies. However, when combined with paclitaxel, low doses of the Mps1 inhibitor reduce paclitaxel-induced mitotic arrest by weakening spindle assembly checkpoint (SAC) activity. Consequently, combination therapy significantly enhances efficacy compared to either paclitaxel or Mps1 inhibitor alone at their respective maximum tolerated doses (MTDs) across a wide range of xenograft models, including those exhibiting acquired or intrinsic paclitaxel resistance. Importantly, BAY 1217389 exhibits good tolerability without increasing toxicity when used in combination with paclitaxel monotherapy[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.78mL 0.36mL 0.18mL |
8.90mL 1.78mL 0.89mL |
17.81mL 3.56mL 1.78mL |
CAS号 | 1554458-53-5 |
分子式 | C27H24F5N5O3 |
分子量 | 561.5 |
SMILES Code | O=C(NC1CC1)C2=CC=C(C3=CN=C4C(NCCC(F)(F)F)=CC(OC5=CC=C(OC)C(F)=C5F)=NN43)C=C2C |
MDL No. | MFCD30502614 |
别名 | |
运输 | 蓝冰 |
InChI Key | WNEILUNVMHVMPH-UHFFFAOYSA-N |
Pubchem ID | 78320750 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|